Health Medical Pharma

Sexual violence against women, girls in Sudan conflict on the rise: UN agencies

HQ Team July 6, 2023: At least 57 women and girls in Sudan were at the receiving end of sexually-related violence since a.

Read More
Drugs Health Pharma

Gene variant discovery may trigger new treatments for multiple sclerosis

HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.

Read More
Drugs Health Pharma

Germany’s Evotec wins $74 million US contract to make drug to fight orthopoxviruses

HQ Team July 5, 2023: Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for.

Read More
Climate Health Pharma

El Nino to ignite global temperatures during rest of 2023; first in 7 years

HQ Team July 4, 2023: Global temperatures, disruptive weather, and climate patterns are set to soar during the July-September period as El Niño.

Read More
Climate Health Pharma

Toothpaste compound may make electric cars safer, travel longer

HQ Team July 4, 2023: Sodium fluoride, a compound found in toothpaste, can enhance and protect the next-generation batteries in electric vehicles, according.

Read More
Drugs Health Pharma

Australia first to allow ecstasy, psilocybin as psychedelics prescriptions

HQ Team July 4, 2023: Australia became the first country to allow authorized psychiatrists to prescribe psychedelic substances psilocybin and methylenedioxy-methamphetamine (MDMA) for.

Read More
Drugs Health Pharma

Samsung Biologics inks $879 million deal with Pfizer to make drugs

HQ Team July 4, 2023: Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, has inked two deals worth $897 million.

Read More
Drugs Health Medical Pharma

Personalised 3D printed medicines seem to be the future of healthcare

HQ Team July3, 2023: 3D printing has expanded from industrial prototyping to healthcare and medicine applications. The method has advanced to allow for.

Read More
Drugs Medical Pharma

Novartis sells eye business to Bausch+Lomb for $2.5 billion

HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,.

Read More
Climate Health Pharma

Scientists hunt ways to unearth hidden structures in 99% of world’s chemical compounds 

HQ Team July 2, 2023: Biological or chemical threats may be lurking in the universe’s chemical world, or cures for disease and tackling.

Read More